In the fiercely competitive world of biopharma, the difference between winning and losing often hinges on one critical factor: timing. As patent cliffs loom and exclusivity periods dwindle, companies are under immense pressure to pivot swiftly, strateg…
In the high-stakes world of pharmaceuticals, timing is everything. As patent cliffs loom and generic competition accelerates, the ability to precisely track patent expiries across different geographies can make or break a company’s strategic planning a…
Track Global Drug Patent Expiry by Geography — Without Hiring a Team of Analysts Read Post »
Is Your Oncology Sales Pipeline at Risk? How to Capitalize on the Patent Cliff Before It’s Too Late
In the rapidly evolving landscape of oncology, pharmaceutical companies are facing an impending challenge that could significantly impact their revenue …
In the rapidly evolving landscape of biopharmaceuticals, the concept of the “patent cliff” isn’t just a looming threat—it’s a strategic battlefield. For industry leaders, understanding how to navigate this cliff can be the difference between maintainin…
In the high-stakes world of pharmaceutical pricing, recent legislative shifts are sending shockwaves through the industry—and the ripple effects are only beginning to unfold. The Inflation Reduction Act (IRA) has introduced a new paradigm, promising to…
The IRA Price Reset: What It Actually Does to Pharma Pricing, and What Comes Next Read Post »
In the relentless race to develop groundbreaking new drugs, the pharmaceutical industry often overlooks a powerful, underutilized strategy: drug repurposing. As highlighted in a compelling article by Drug Patent Watch, "No Patents, No Problem: The…
No Patents, No Problem: The Untapped Power of Drug Repurposing Read Post »
In the high-stakes world of pharmaceutical innovation, the race to bring a new drug to market is only part of the story. Once a blockbuster drug hits the shelves, the real battle begins—fending off generic challengers eager to carve out their share of …
Beyond the API: Mapping the Secondary Patent Thicket to Forecast Generic Entry Read Post »
In today’s fiercely competitive healthcare landscape, specialty pharmacies are under relentless pressure to boost margins while maintaining top-tier patient care. But what if there was a game-changing strategy that could double your specialty pharmacy …
Double Your Specialty Pharmacy Margins the Day Generics Launch Read Post »
In the high-stakes world of pharmaceuticals, blockbuster drugs are more than just revenue generators—they’re strategic assets that can define a company’s future. But with great success comes great vulnerability. Patent challenges, generic threats, and …
Defend Your Blockbuster Drug. Here’s the Playbook. Read Post »
ð¨ The Truth About Drug Patents and Stock Success: Overnight Millionaires or Decades-Long Marathon? ð¨
In the high-stakes world of biotech and pharmaceutical investing, there’s a common myth that securing a drug patent is a quick ticket to overnigh…